83 related articles for article (PubMed ID: 16284609)
1. Long-term remission after autologous peripheral blood stem cell transplantation for relapsed intravascular lymphoma.
Sawamoto A; Narimatsu H; Suzuki T; Kurahashi S; Sugimoto T; Sugiura I
Bone Marrow Transplant; 2006 Jan; 37(2):233-4. PubMed ID: 16284609
[No Abstract] [Full Text] [Related]
2. Effective in vivo purging with rituximab and autologous peripheral blood stem cell transplantation in a woman with CD5 positive primary cutaneous diffuse large B-cell lymphoma.
Goto H; Nishio M; Endo T; Sato N; Koizumi K; Fujimoto K; Sakai T; Kumano K; Obara M; Koike T
Eur J Haematol; 2005 Jun; 74(6):526-8. PubMed ID: 15876258
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcome following autologous and allogeneic blood and marrow transplantation for relapsed diffuse large-cell non-Hodgkin's lymphoma.
Aksentijevich I; Jones RJ; Ambinder RF; Garrett-Mayer E; Flinn IW
Biol Blood Marrow Transplant; 2006 Sep; 12(9):965-72. PubMed ID: 16920563
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic results in patients with relapsed diffuse large B cell Non-Hodgkin's lymphoma achieving complete response only after autologous stem cell transplantation.
Ferrara F; Viola A; Copia C; Schiavone EM; Celentano M; Pollio F; D'Amico MR; Palmieri S
Hematol Oncol; 2006 Jun; 24(2):73-7. PubMed ID: 16550628
[TBL] [Abstract][Full Text] [Related]
5. Successful autologous peripheral blood stem cell transplantation with rituximab administration for pediatric diffuse large B-cell lymphoma.
Imamura T; Yoshihara T; Morimoto A; Ishida H; Sugimoto T; Imashuku S
Pediatr Hematol Oncol; 2006; 23(1):19-24. PubMed ID: 16326408
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune thrombocytopenia with clonal expansion of CD8-positive T cells after autologous peripheral blood stem cell transplantation for diffuse large B-cell lymphoma.
Isobe T; Tanimoto TE; Nakaji G; Miyamoto T; Yamasaki S; Takase K; Numata A; Fukuda T; Nagafuji K; Inaba S; Harada M
Bone Marrow Transplant; 2005 Feb; 35(3):315-6. PubMed ID: 15568035
[No Abstract] [Full Text] [Related]
7. Rituximab does not compromise the mobilization and engraftment of autologous peripheral blood stem cells in diffuse-large B-cell lymphoma.
Kamezaki K; Kikushige Y; Numata A; Miyamoto T; Takase K; Henzan H; Aoki K; Kato K; Nonami A; Kamimura T; Arima F; Takenaka K; Harada N; Fukuda T; Hayashi S; Ohno Y; Eto T; Harada M; Nagafuji K
Bone Marrow Transplant; 2007 May; 39(9):523-7. PubMed ID: 17369863
[TBL] [Abstract][Full Text] [Related]
8. Long-term remission in a patient with hepatosplenic gammadelta T cell lymphoma after cord blood stem cell transplantation following autologous peripheral blood stem cell transplantation.
Sakai R; Fujisawa S; Fujimaki K; Kanamori H; Ishigatsubo Y
Bone Marrow Transplant; 2006 Mar; 37(5):537-8. PubMed ID: 16415891
[No Abstract] [Full Text] [Related]
9. A long-lasting third complete remission after second autologous transplant followed by maintenance treatment with rituximab in a patient with diffuse large cell non-Hodgkin's lymphoma.
Ataergin S; Arpaci F; Beyzadeoglu M; Safali M; Ozet A
Am J Hematol; 2006 Dec; 81(12):986-7. PubMed ID: 16886214
[No Abstract] [Full Text] [Related]
10. Autologous stem cell transplantation in elderly patients (> or =60 years) with diffuse large B-cell lymphoma: an analysis based on data in the European Blood and Marrow Transplantation registry.
Jantunen E; Canals C; Rambaldi A; Ossenkoppele G; Allione B; Blaise D; Conde E; Tilly H; Cook G; Clark F; Gallamini A; Haynes A; Mounier N; Dreger P; Pfreundschuh M; Sureda A;
Haematologica; 2008 Dec; 93(12):1837-42. PubMed ID: 18838474
[TBL] [Abstract][Full Text] [Related]
11. The International Prognostic Index assessed at relapse predicts outcomes of autologous transplantation for diffuse large-cell non-Hodgkin's lymphoma in second complete or partial remission.
Lerner RE; Thomas W; Defor TE; Weisdorf DJ; Burns LJ
Biol Blood Marrow Transplant; 2007 Apr; 13(4):486-92. PubMed ID: 17382255
[TBL] [Abstract][Full Text] [Related]
12. Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas.
Schütt P; Passon J; Ebeling P; Welt A; Müller S; Metz K; Moritz T; Seeber S; Nowrousian MR
Eur J Haematol; 2007 Feb; 78(2):93-101. PubMed ID: 17313557
[TBL] [Abstract][Full Text] [Related]
13. High-dose therapy and autologous stem cell transplantation in patients with diffuse large B-cell lymphoma in first complete or partial remission.
Papajik T; Raida L; Faber E; Vondrakova J; Prochazka V; Kubova Z; Skoumalova I; Jarosova M; M LK; Paucek B; Myslivecek M; Neoral C; Oral I; Jarkovsky J; Dusek L; Indrak K
Neoplasma; 2008; 55(3):215-21. PubMed ID: 18348654
[TBL] [Abstract][Full Text] [Related]
14. Enteropathy-type T-cell lymphoma after intestinal diffuse large B-cell lymphoma.
Nava VE; Cohen P; Bishop M; Fowler D; Jaffe ES; Ozdemirli M
Am J Surg Pathol; 2007 Mar; 31(3):476-80. PubMed ID: 17325491
[TBL] [Abstract][Full Text] [Related]
15. Successful autologous peripheral blood stem cell harvest and transplant in a patient with cold agglutinins.
Crowther H; Collins D; Antonenas V; McGurgan M; Kerridge I; Gottlieb D; Bradstock K
Bone Marrow Transplant; 2006 Feb; 37(3):329-30. PubMed ID: 16299542
[No Abstract] [Full Text] [Related]
16. Long-term follow-up of patients with non-Hodgkin lymphoma following myeloablative therapy and autologous transplantation of CD34+-selected peripheral blood progenitor cells.
Witzens-Harig M; Heilmann C; Hensel M; Kornacker M; Benner A; Haas R; Fruehauf S; Ho AD
Stem Cells; 2007 Jan; 25(1):228-35. PubMed ID: 17204607
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma].
Huang HQ; Bu Q; Xia ZJ; Lin XB; Wang FH; Li YH; Peng YL; Pan ZH; Wang SS; Lin TY; Jiang WQ; Guan ZZ
Ai Zheng; 2006 Apr; 25(4):486-9. PubMed ID: 16613686
[TBL] [Abstract][Full Text] [Related]
18. Rituximab long-term maintenance therapy after autologous stem cell transplantation in patients with B-cell non-Hodgkin's lymphoma.
Neumann F; Harmsen S; Martin S; Kronenwett R; Kondakci M; Aivado M; Germing U; Haas R; Kobbe G
Ann Hematol; 2006 Aug; 85(8):530-4. PubMed ID: 16639571
[TBL] [Abstract][Full Text] [Related]
19. [Long-term complete remission in primary plasma cell leukemia after treatment with VAD chemotherapy and tandem autologous peripheral blood stem cell transplantation].
Iino M; Nakajima A; Shindo H
Gan To Kagaku Ryoho; 2008 Dec; 35(13):2441-3. PubMed ID: 19098420
[TBL] [Abstract][Full Text] [Related]
20. Durable remission of large B-cell lymphoma transformed from lymphoplasmacytic lymphoma/Waldenström macroglobulinemia successfully treated with sequential immunochemotherapy followed by reduced-intensity allogeneic stem cell transplantation.
Yamamoto R; Takaori-Kondo A; Kanda J; Imada K; Ichinohe T; Ishikawa T; Ohmori K; Uchiyama T
Bone Marrow Transplant; 2008 Mar; 41(6):591-3. PubMed ID: 18071292
[No Abstract] [Full Text] [Related]
[Next] [New Search]
